<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03342222</url>
  </required_header>
  <id_info>
    <org_study_id>JMST-01</org_study_id>
    <nct_id>NCT03342222</nct_id>
  </id_info>
  <brief_title>The Safety and Effectiveness of PEEK Interference Screws in Anterior Cruciate Ligament Reconstruction</brief_title>
  <official_title>Multi-center, Randomized, Open, Parallel, Noninferiority Clinical Trial to Evaluate the Safety and Effectiveness of PEEK Interference Screws in Anterior Cruciate Ligament Reconstruction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central South University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Rejoin Hangzhou Martins Medical Equipment Co., Ltd.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Central South University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Anterior cruciate ligament (ACL) rupture is one of the most common injuries in sports
      medicine. ACL reconstructions are usually performed to restore the stability of knee joint
      and prevent the secondary meniscal and chondral lesions.

      120 Subjects with ACL injury were randomly assigned to two groups for ACL
      reconstruction.Group one: tibial fixation with PEEK Interference Screws (Rejoin Hangzhou
      Martins Medical Equipment Co., Ltd.);Group two: tibial fixation with Biosure PK interference
      screw (Smith &amp; Nephew plc). The subjects will be followed by 12 months after surgery for
      evaluations.Outcome measures included Lysholm score,IKDC, ADT,Lachman.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 20, 2017</start_date>
  <completion_date type="Anticipated">November 20, 2019</completion_date>
  <primary_completion_date type="Anticipated">November 20, 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>percentage of patients with Lysholm score more than 70 score</measure>
    <time_frame>12 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lysholm score</measure>
    <time_frame>1month; 3month; 6 month; 12 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IKDC</measure>
    <time_frame>1month; 3month; 6 month; 12 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anterior drawer test</measure>
    <time_frame>1month; 3month; 6 month; 12 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lachman test</measure>
    <time_frame>1month; 3month; 6 month; 12 month</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>PEEK Interference Screw; Fixation; Anterior Cruciate Ligament Reconstruction</condition>
  <arm_group>
    <arm_group_label>PEEK Interference Screws</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PEEK Interference Screws provided by Ruijin Hangzhou Martins Medical Equipment Co., Ltd.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Biosure PK interference screw</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Biosure PK interference screw from Smith &amp; Nephew plc.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Interference Screws</intervention_name>
    <description>tibial fixation for ACL reconstruction</description>
    <arm_group_label>PEEK Interference Screws</arm_group_label>
    <arm_group_label>Biosure PK interference screw</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Voluntarily sign the informed consent form; Between the ages of 18 and 75; Positive ADT and
        positive Lachman test. Unilateral anterior cruciate ligament is confirmed by MRI (without
        posterior cruciate ligament injury or reconstruction); Tolerated for anterior cruciate
        ligament reconstruction surgery; Normal contralateral knee

        Exclusion Criteria:

          1. Do not meet the diagnostic criteria of anterior cruciate ligament injury;

          2. With posterior cruciate ligament fracture at the same time;

          3. X-ray showed a significant degeneration of the knee (more than four degrees of
             cartilage injury);

          4. Knee flexion less than 90 degree;

          5. Abnormal body anatomy;

          6. Pregnant, breast-feeding or subjects who plan to become pregnant;

          7. Serious osteoporosis, malignant tumors;

          8. Allergic to implant materials;

          9. Patients with severe malnutrition who can not tolerate surgery;

         10. Severe coagulopathy, such as hemophilia;

         11. Immunodeficiency diseases, including those requiring long-term use of
             immunosuppressive agents;

         12. The injured knee has a wide range of skin diseases;

         13. Serious obese patients (BMI&gt; 35);

         14. Patients with severe mental illness can not cooperate with postoperative
             rehabilitation and patients with severe cardiopulmonary disease can not tolerate
             surgery;

         15. Ipsilateral lower extremity received surgery within the past year;

         16. Has participated in any other clinical trial in the past three months;

         17. Can not comply with the requirements of the study;

         18. Those who the investigator thinks they are inappropriate.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Xi He, MD</last_name>
    <phone>86-073189753059</phone>
    <email>hongbinlu@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Xiangya Hospital, Central South University</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <zip>410008</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lu Hongbin, M.D. &amp; Ph.D.</last_name>
      <phone>86-0731-84327174</phone>
      <email>hongbinlu@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 9, 2017</study_first_submitted>
  <study_first_submitted_qc>November 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 14, 2017</study_first_posted>
  <last_update_submitted>April 27, 2018</last_update_submitted>
  <last_update_submitted_qc>April 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 30, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Central South University</investigator_affiliation>
    <investigator_full_name>Hongbin Lu</investigator_full_name>
    <investigator_title>Porfessor</investigator_title>
  </responsible_party>
  <keyword>PEEK Interference Screw; Fixation; Anterior Cruciate Ligament Reconstruction</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

